{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:36:41Z","timestamp":1793522201142,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018835","name":"NIHR Sheffield Clinical Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000858","name":"University of Sheffield","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022665","name":"Weston Park Cancer Charity","doi-asserted-by":"publisher","award":["CA133"],"award-info":[{"award-number":["CA133"]}],"id":[{"id":"10.13039\/501100022665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jbo.2024.100611","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:39:00Z","timestamp":1718739540000},"page":"100611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study)"],"prefix":"10.1016","volume":"47","author":[{"given":"Catherine","family":"Handforth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Paggiosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Gossiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2024.100611_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbo.2024.100611_b0010","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ijrobp.2012.11.007","article-title":"Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy","volume":"85","author":"Choo","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jbo.2024.100611_b0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbo.2024.100611_b0020","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/cncr.24404","article-title":"Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma","volume":"115","author":"Satoh","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2024.100611_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100465","article-title":"High prevalence of vertebral fractures at initiation of androgen deprivation therapy for prostate cancer","volume":"38","author":"van Oostwaard","year":"2023","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.jbo.2024.100611_b0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"17","author":"Mazziotti","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2024.100611_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.semnuclmed.2009.08.001","article-title":"An update on dual-energy x-ray absorptiometry","volume":"40","author":"Blake","year":"2010","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.jbo.2024.100611_b0040","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s11999-010-1766-x","article-title":"High-resolution computed tomography for clinical imaging of bone microarchitecture","volume":"469","author":"Burghardt","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jbo.2024.100611_b0045","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1210\/jc.2010-0902","article-title":"Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy","volume":"95","author":"Hamilton","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2024.100611_b0050","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/jbmr.3746","article-title":"Relationship between sex steroids and deterioration of bone microarchitecture in older men: the prospective STRAMBO study","volume":"34","author":"Piot","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2024.100611_b0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/EJE-22-0227","article-title":"Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial","volume":"187","author":"Russell","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbo.2024.100611_b0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/jjco\/hyaa045","article-title":"Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer","volume":"50","author":"Ikeda","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100611_b0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jbo.2024.100611_b0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","article-title":"The prevalence and outcomes of frailty in older cancer patients: a systematic review","volume":"26","author":"Handforth","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2024.100611_b0075","first-page":"2604","article-title":"Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?","volume":"110","author":"Bylow","year":"2007","journal-title":"A Conceptual Review. Cancer"},{"key":"10.1016\/j.jbo.2024.100611_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-013-9798-3","article-title":"Precision of high-resolution peripheral quantitative computed tomography measurement variables: influence of gender, examination site, and age","volume":"94","author":"Paggiosi","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jbo.2024.100611_b0085","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1038\/s41598-017-11700-4","article-title":"Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbo.2024.100611_b0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bone.2011.03.755","article-title":"Quantitative characterisation of subject motion in HR-pQCT images of the distal radius and tibia","volume":"48","author":"Sode","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2024.100611_b0095","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00198-011-1829-1","article-title":"Short-term in vivo precision of BMD and parameters of trabecular architecture at the distal forearm and tibia","volume":"23","author":"Engelke","year":"2012","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbo.2024.100611_b0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bone.2010.05.034","article-title":"Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT","volume":"47","author":"Burghardt","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2024.100611_b0105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1359\/jbmr.071108","article-title":"Finite element analysis based on in vivo HR-pQCT images of the radius is associated with wrist fracture in postmenopausal women","volume":"23","author":"Boutroy","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2024.100611_b0110","unstructured":"2023 ISCD Official Positions Adult. https:\/\/iscd.org\/wp-content\/uploads\/4\/03\/3-ISCD-Adult-Positions.pdf (accessed 8 May 4)."},{"key":"10.1016\/j.jbo.2024.100611_b0115","series-title":"Sarcopenia: Revised European consensus on definition and diagnosis","first-page":"16","author":"Cruz-Jentoft","year":"2019"},{"key":"10.1016\/j.jbo.2024.100611_b0120","unstructured":"frax.shef.ac.uk\/FRAX\/tool.aspx?country=9."},{"key":"10.1016\/j.jbo.2024.100611_b0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Cardiovascular health study collaborative research group. frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jbo.2024.100611_b0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.071020","article-title":"A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men","volume":"23","author":"Riggs","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2024.100611_b0135","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1073\/pnas.1533500100","article-title":"Suppressive function of androgen receptor in bone resorption","volume":"100","author":"Kawano","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbo.2024.100611_b0140","first-page":"401","article-title":"Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis","volume":"8","author":"Kontulainen","year":"2008","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.jbo.2024.100611_b0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bone.2019.06.005","article-title":"Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy","volume":"127","author":"Dalla Via","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2024.100611_b0150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2012.10.036","article-title":"High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis","volume":"52","author":"Graeff","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2024.100611_b0155","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1017\/S0007114520002172","article-title":"Sarcopenic obesity in ageing: Cardiovascular outcomes and mortality","volume":"124","author":"Atkins","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jbo.2024.100611_b0160","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.juro.2014.12.086","article-title":"The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy","volume":"93","author":"Morote","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.jbo.2024.100611_b0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2010.03942.x","article-title":"Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy","volume":"74","author":"Hamilton","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jbo.2024.100611_b0170","first-page":"141","article-title":"Androgen deprivation therapy for prostate cancer: effects on hand function","volume":"26","author":"Soyupek","year":"2008","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.jbo.2024.100611_b0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00198-013-2462-y","article-title":"Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids","volume":"25","author":"Garc\u00eda-Fontana","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbo.2024.100611_b0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAXTM and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbo.2024.100611_b0185","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00198-012-2215-3","article-title":"Performance of FRAX in a cohort of community dwelling, ambulatory older men: the osteoporotic fractures in men (MrOS) study","volume":"24","author":"Ettinger","year":"2013","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbo.2024.100611_b0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.afos.2019.11.001","article-title":"Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy","volume":"5","author":"Kojima","year":"2019","journal-title":"Osteoporos. Sarcopenia"},{"key":"10.1016\/j.jbo.2024.100611_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/924595","article-title":"Predictors of fracture risk and bone mineral density in men with prostate cancer on androgen deprivation therapy","volume":"2011","author":"Neubecker","year":"2011","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.jbo.2024.100611_b0200","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-020-05438-5","article-title":"Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography","volume":"31","author":"Whittier","year":"2020","journal-title":"Osteoporos Int."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137424000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137424000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:22:10Z","timestamp":1723004530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137424000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"alternative-id":["S2212137424000915"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2024.100611","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study)","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2024.100611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100611"}}